Aljehani Ala M, Banjar Shaima A, Alawam Hadil Sultan, Alowais Shams, Aldraibi Yara, BinSaif Asayel, Alasiri Glowi
College of Medicine, Al-Imam Mohammed Ibn Saud Islamic University, Riyadh, SAU.
Department of Family Medicine, King Abdulaziz Medical City National Guard Hospital, Riyadh, SAU.
Cureus. 2023 Dec 2;15(12):e49841. doi: 10.7759/cureus.49841. eCollection 2023 Dec.
Background After COVID-19 vaccination, females reported irregularities and changes in their menstrual cycle. We aimed to explore the menstrual irregularities following COVID-19 vaccination in Saudi women of childbearing age. Methodology The study was a cross-sectional study conducted among women in Riyadh, Saudi Arabia, who had no history of menstrual irregularities before receiving the first dose of the COVID-19 vaccine. The participants filled out an online self-administered questionnaire via Google Form about any menstrual irregularities they experienced after receiving the COVID-19 vaccine. Results A total of 535 participants completed the survey. The study found that 41.7% (223) of women experienced menstrual changes after the first dose of the COVID-19 vaccine, increasing to 44.1% (236) after the second dose. The incidence of these changes varied between the first and second doses. For example, the incidence of changes in period duration decreased from 51.6% to 48.3% after the first and second doses, respectively. Similarly, the incidence of delayed periods decreased from 48.4% to 47.9%, while dysmenorrhea increased slightly from 30.9% to 32.2% after the two doses. The incidence of heavier menstrual flow increased from 26.9% to 30.5%, while the incidence of lighter menstrual flow decreased from 26.9% to 24.6% after the first and second doses, respectively. Conclusions There is an increased incidence of changes in menstrual cycle after COVID-19 vaccination, particularly in menstrual cycle length, menstrual pain, and the flow of menstruation. Future studies are needed to investigate the potential underlying biological mechanisms.
在接种新冠疫苗后,女性报告了月经周期的异常和变化。我们旨在探究沙特育龄期女性接种新冠疫苗后的月经异常情况。
本研究为横断面研究,在沙特阿拉伯利雅得的女性中开展,这些女性在接种第一剂新冠疫苗前无月经不规律病史。参与者通过谷歌表单填写一份关于接种新冠疫苗后所经历的任何月经异常情况的在线自填问卷。
共有535名参与者完成了调查。研究发现,41.7%(223名)的女性在接种第一剂新冠疫苗后出现月经变化,接种第二剂后这一比例增至44.1%(236名)。这些变化的发生率在第一剂和第二剂之间有所不同。例如,经期时长变化的发生率在接种第一剂和第二剂后分别从51.6%降至48.3%。同样,经期推迟的发生率从48.4%降至47.9%,而痛经在接种两剂后从30.9%略有增至32.2%。经量增多的发生率从26.9%增至30.5%,而经量减少的发生率在接种第一剂和第二剂后分别从26.9%降至24.6%。
接种新冠疫苗后月经周期变化的发生率增加,尤其是在月经周期长度、痛经和月经量方面。未来需要开展研究来调查潜在的生物学机制。